LINK WILLIAM J PHD (CIK 1228684) reported 18 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-18). Recent activity: Buy RXST (37,037 shares), Sell TARS (10,572 shares), Sell TARS (1,928 shares), Buy TARS (2,954 shares), Buy LNSR (17,421 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | RxSight, Inc. (RXST) | Director | Buy | 37,037 | $0 |
| 2026-06-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Director | Sell | 10,572 | $655,147 |
| 2026-06-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Director | Sell | 1,928 | $121,348 |
| 2026-06-16 | Tarsus Pharmaceuticals, Inc. (TARS) | Director | Buy | 2,954 | $0 |
| 2026-06-05 | LENSAR, Inc. (LNSR) | Director | Buy | 17,421 | $0 |
| 2026-03-18 | Tarsus Pharmaceuticals, Inc. (TARS) | Director | Sell | 3,629 | $247,099 |
| 2026-03-18 | Tarsus Pharmaceuticals, Inc. (TARS) | Director | Sell | 8,378 | $578,333 |
| 2026-03-18 | Tarsus Pharmaceuticals, Inc. (TARS) | Director | Sell | 493 | $34,387 |
| 2025-12-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Director | Sell | 5,046 | $407,717 |
| 2025-12-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Director | Sell | 6,306 | $515,516 |
| 2025-12-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Director | Sell | 1,148 | $94,584 |
| 2025-12-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Director | Sell | 5,680 | $458,433 |
| 2025-12-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Director | Sell | 4,766 | $388,429 |
| 2025-09-18 | Tarsus Pharmaceuticals, Inc. (TARS) | Director | Sell | 2,000 | $0 |
| 2025-09-10 | Tarsus Pharmaceuticals, Inc. (TARS) | Director | Sell | 27,116 | $1.5M |
| 2025-06-16 | Tarsus Pharmaceuticals, Inc. (TARS) | Director | Buy | 3,350 | $0 |
| 2025-06-04 | RxSight, Inc. (RXST) | Director | Buy | 10,752 | $0 |
| 2025-05-28 | LENSAR, Inc. (LNSR) | Director | Buy | 7,374 | $0 |
Source: SEC Form 4 filings · as of 2026-06-18